Skip to main content
SpringerLink
Log in

Grundprinzipien medikamentöser Therapie und allgemeiner Lebensweise

  • Chapter
Kardiologie kompakt

  • 152 Accesses

Zusammenfassung

Nitroglycerin ist seit weit über 100 Jahren für seine prompte Wirksamkeit bei der Angina pectoris bekannt. Es wirkt so sicher, daß es auch zur Differentialdiagnose von Brustschmerzen verwendet wird. Seitdem der Wirkungsmechanismus aufgeklärt werden konnte, spricht man von der Gruppe der NO-Donatoren, die auch andere chemische Stoffe mit gleichem Wirkmechanismus umfaßt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur zu Kap.16

  1. Ascherio A, Rimm EB, Giovannucci EL et al. (1996) Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313:84–90

    Article  PubMed  CAS  Google Scholar 

  2. Borchard U (1988) Klinische Pharmakologie der Betarezeptorenblocker. Aesopus-Verlag, Basel

    Google Scholar 

  3. Collins R, Peto R, Baigent C, Sleight P (1997) Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 336:847–860

    Article  PubMed  CAS  Google Scholar 

  4. Fuster V, Ross S, Topol EJ (eds) (1996) Atherosclerosis and Coronary Artery Disease. Lippincott — Raven, Philadelphia New York

    Google Scholar 

  5. Ganz W, Marcus HS (1972) Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation 46:880–889

    Article  PubMed  CAS  Google Scholar 

  6. Garber AM, Browner WS (1996) American College of Physicians guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Ann Intern Med 124:515–517

    Google Scholar 

  7. Hlatky MA, Lam LC, Lee KL et al. (1995) Job strain and the prevalence and outcome of coronary artery disease. Circulation 92: 327–333

    Article  PubMed  CAS  Google Scholar 

  8. Hopf R, Kaltenbach M (Hrsg) (1996) Therapieschemata Kardiologie, 2. Aufl. Urban und Schwarzenberg, München Wien Baltimore

    Google Scholar 

  9. Immig H (1995) Keine Chancengleichheit: Die skandinavische Simvastatinstudie. Internist Prax 35:649–653

    Google Scholar 

  10. Immig H (1997) Lassen sich Privastatinwirkungen objektivieren? Internist Prax 37:425–434

    Google Scholar 

  11. Jarlwalla AJ, Anderson EG (1978) Production of ischemic cardiac pain by nifedipine. Br Med 1:1181–1182

    Article  Google Scholar 

  12. Kaltenbach M (1970) Medikamentöse Therapie der Angina pectoris. Drug Res 20:1304–1310

    CAS  Google Scholar 

  13. Klepzig H Jr, Kaltenbach M (1992) Cholesterinsenkung und Lebenserwartung: Eine kritische Stellungnahme. Z Kardiol 81: 347–353

    PubMed  Google Scholar 

  14. Lohmüller G, Lydtin H (1984) Betarezeptorenblocker. In: Roskamm H (Hrsg) Handbuch der Inneren Medizin, Koronarerkrankungen. Springer, Berlin Heidelberg Tokyo New York

    Google Scholar 

  15. Ridker PM, Cushman M, Stampfer J et al. (1997) Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979

    Article  PubMed  CAS  Google Scholar 

  16. Ryan T et al. (1996) QACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction. Circulation 94:2341–2350

    Article  PubMed  CAS  Google Scholar 

  17. Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Survival Study. Lancet 344:1383–1389

    Google Scholar 

  18. Schulz W, Jost S, Kober G, Kaltenbach M (1985) Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels. Am J Cardiol 55:26–32

    Article  PubMed  CAS  Google Scholar 

  19. Shepherd J, Cobbe SM, Ford I et al. for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307

    Article  PubMed  CAS  Google Scholar 

  20. Sievert H, Selzer G, Schneider W et al. (1989) Coronary stenosis dilation by low dose intravenous nitroglycerin. Eur Heart J 10 (Suppl F): 134–136

    PubMed  Google Scholar 

  21. Task Force on Risk Reduction (1996) Cholesterol screening in asymptomatic adults: no cause to chance. Circulation 93:1067–1068

    Article  Google Scholar 

Download references

Authors
  1. M. Kaltenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kardiologisches Centrum, Pfingstweidstraße 9, 60316, Frankfurt/Main, Germany

    Martin Kaltenbach

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kaltenbach, M. (2000). Grundprinzipien medikamentöser Therapie und allgemeiner Lebensweise. In: Kaltenbach, M. (eds) Kardiologie kompakt. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57728-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57728-4_16

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1153-8

  • Online ISBN: 978-3-642-57728-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation